METABOLIC TECHNOLOGIES, INC.

UNCERTAIN · Still private

Nutritional supplement combining HMB (2-hydroxy-2-methylbutyrate) and Vitamin D to treat age-related muscle loss (sarcopenia)

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
UNCERTAIN
Total capital
$1.4M
Federal grants
$1.4M
5 awards · 2016–2017
5.0× sector median 1 award
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
16
24 pending · first 2016

Capital timeline

20162017FEDERAL ↑EQUITY ↓Cumulative $1.4M$375K$672K$78K$98K$151K
20162017FEDERAL ↑EQUITY ↓Cumulative $1.4M$375K$672K$98K$151K

Latest events

  • Federal grantHealth and Human S · Phase II · 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans$151K
  • Federal grantHealth and Human S · Phase II · Nutritional Intervention for Age-Related Muscular Function and Strength Losses$98K
  • Federal grantHealth and Human S · Phase II · 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans$78K
  • Federal grantHealth and Human S · Phase II · 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans$672K
  • Federal grantHealth and Human S · Phase II · Nutritional Intervention for Age-Related Muscular Function and Strength Losses$375K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 16 granted of 40
Show all 40 patent records

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .